Latest funding led by Bessemer Venture Partners will accelerate continued expansion as the Fortune 500 rapidly scale AI coaching initiatives

NEW YORK, Sept. 25, 2025 — Valence, the company behind Nadia, the world’s first enterprise AI coach, today announced it has raised a $50 million Series B led by Bessemer Venture Partners. Sameer Dholakia, Partner at Bessemer, will join Valence’s board, bringing both CEO operating experience and perspective from AI investments in Anthropic, Abridge, and EvenUp.

Valence is pioneering a new category of enterprise software: AI coaching. Nadia, its flagship AI coach, is now deployed at scale across Fortune 500 companies, including Experian, Delta Air Lines, Kraft Heinz, and General Mills. Across 50+ global deployments and one million coaching conversations, Nadia has consistently had NPS scores of 90+.

Nadia democratizes access to high-quality, personalized coaching, which was once an investment only available to the most senior executives. Nadia also provides a channel for HR teams to tackle some of the most pressing challenges of modern work — adapting to AI and new ways of working, addressing rising burnout across industries, and enabling the largest companies to operate at the speed of technological change.

“AI coaching represents an entirely new category of enterprise software, one that is both deeply personal for the individual and transformational for HR at scale,” said Dholakia. “With Nadia, Valence has proven that AI can democratize access to effective, context-rich coaching. We see Valence as an extraordinary example of how AI can dramatically improve the lives and careers of all employees.”

Valence has been building Nadia since December 2022, launching the coach in early 2023, making Nadia the first AI coach to market. Today, it is one of the most advanced agentic AI systems in use at global scale. Unlike general AI models, Nadia is powered by a proprietary memory-and-context engine, and each deployment is customized to a company’s culture, workflows, and leadership models to deliver coaching that is personalized, actionable, and right there in the flow of work.

Enterprises are seeing measurable impact with Nadia. Experian has embedded Nadia into its performance management process, with a third of its global workforce now actively using the coach. Delta Air Lines has rolled Nadia out to frontline leaders to provide real-time support and improve customer service across large teams. Analog Devices has given Nadia to its global workforce, supporting first-time technical managers with leadership coaching in 30+ languages.

“We’ve been closely monitoring the AI space, especially coaching, and Nadia stood out. We brought her in last year to scale personalized coaching across ADI, and employees loved it. We are now doubling down, customizing her to all things Analog Devices and beginning to deeply embed her in our talent strategy and programs. We’re very excited about how Nadia can bring a more personalized, people-oriented talent strategy to life,” said Mariya Trickett, Chief People Officer at Analog Devices.

Valence will use the new funding to accelerate product development, expand go-to-market efforts, deepen partnerships with the world’s largest enterprises, and grow the team. The company is actively recruiting for roles worldwide, and interested candidates can explore opportunities at valence.ai/careers. Valence is also investing heavily in governance, security, and trust—ensuring that Nadia is not only compliant with global standards but designed with safety and responsibility as first principles.

“Every worker will have an AI coach,” said Parker Mitchell, co-founder and CEO of Valence. “The question is whether that coach simply gives answers, or whether it truly transforms how people learn, perform, and work together. Nadia is the first enterprise AI coach that helps people and organizations thrive in the AI era.”

About Valence

Valence is the creator of Nadia, the most widely deployed and deeply trusted AI coach across the Fortune 500. Leading enterprises, including Experian, Delta Air Lines, Prudential, WPP, and General Mills, use Nadia at scale. With over one million coaching conversations and counting, Nadia empowers people in their daily work. Purpose-built for the enterprise, Nadia combines personalization, context, and organizational alignment to help every employee perform at their best while giving HR leaders a transformative platform to drive culture, performance, and development globally. Learn more at https://www.valence.co.

SOURCE Valence

Funding supports clinical trials of a minimally invasive therapy targeting a root cause of heart failure; co-founder Zoar Engelman, PhD, appointed CEO

NEW YORK, Sept. 25, 2025 — Axon Therapies, a clinical-stage medical device company pioneering a new approach to treating heart failure, today announced the close of an oversubscribed $32 million Series A financing. The round was co-led by new investors Earlybird Venture Capital and Santé Ventures, with participation by existing investor Deerfield Management and new investors CD Capital and KOFA Healthcare.

The financing will accelerate Axon’s next phase of clinical development, including two double-blinded randomized feasibility studies in heart failure – a condition that affects millions of people worldwide with limited treatment options. The first is a confirmatory study for its novel splanchnic ablation therapy in patients with Heart Failure with Preserved Ejection Fraction (HFpEF). The second is a multiple-center study of splanchnic ablation in Failure with Reduced Ejection Fraction (HFrEF).

In conjunction with the financing, the company announced that Zoar Engelman, PhD, Axon’s co-founder and former Chief Scientific Officer, has been appointed Chief Executive Officer.

“Heart failure is one of the leading causes of hospitalization and death worldwide, yet patients still face a lack of effective treatment options,” said Dr. Engelman, CEO of Axon Therapies. “Our implant-free, minimally invasive therapy is designed to address a core physiological driver of the disease. This funding positions us to advance to pivotal trials and bring hope to patients who urgently need new solutions.”

Axon’s proprietary approach, Splanchnic Ablation for Volume Management (SAVM), targets overactivity in the sympathetic nervous system, a key mechanism that worsens heart failure. The company’s Satera™ Ablation System is a catheter-based, implant-free procedure that has the potential to slow disease progression and improve quality of life for patients.

Axon Therapies has also established a new European headquarters, Axon Vascular Europe Ltd, in the UK. “The opening of our new European headquarters in the UK provides a focused hub to accelerate our clinical trial efforts and strategically positions us for future entry into the large European heart failure market,” noted Dr. Engelman.

“Our investment in Axon Therapies was driven by a clear vision to address a large unmet clinical need and improve the lives of patients with heart failure,” said Dr. John Yianni, Partner at Earlybird Venture Capital. “With Dr. Engelman’s leadership and the team’s groundbreaking technology, we are excited to support Axon as they advance solutions that can make a real difference for patients and their families.”

“Axon’s technology represents a first-in-class solution poised to capture a multi-billion-dollar market, making it a highly attractive asset for any major cardiovascular player,” added Dr. James Eadie, Managing Director and Partner at Santé Ventures. “These randomized feasibility studies are designed to significantly de-risk the therapy and establish a strong foundation ahead of a pivotal trial, creating what we believe will be a cornerstone technology for the right strategic partner.”

About Heart Failure

Heart failure affects more than 64 million people globally and is responsible for over 1 million hospitalizations annually in the U.S. alone. Despite advances in pharmaceuticals and devices, many patients remain symptomatic with few effective options.

About Axon Therapies

Axon Therapies is a private MedTech company developing minimally invasive therapies that address the root causes of heart failure. Its lead innovation, SAVM using the Satera™ Ablation System, enables targeted ablation of the overactive sympathetic nervous system without the need for an implant. Founded by MedTech incubator Coridea, Axon is backed by healthcare investors including Deerfield Management, Earlybird Venture Capital, Sante Ventures, CD Capital, and KOFA Healthcare.

Learn more at www.axontherapies.com.

Photo – https://mma.prnewswire.com/media/2782398/Axon_Zoar_Engelman.jpg

Logo – https://mma.prnewswire.com/media/2782273/Axon_Logo___Primary__1_Logo.jpg

Burnt’s AI Agents Automate Operational Workflows Stuck in Legacy Systems & Manual Inputs

SAN FRANCISCO, Sept. 25, 2025 — Burnt today announced a $3.8M seed funding to build an AI-powered OS to automate repetitive operational work slowing down the global food supply chain, an integral part of the $9 trillion food industry. Burnt’s agentic platform automates monotonous workflows stuck in ERPS, working with existing legacy systems to accelerate them, not replace them. The round is led by Penny Jar Capital, with participation from Scribble Ventures, Formation VC, and prominent angel investors, including Dan Scheinman, food industry leaders and AI influencers.

“The food supply chain runs on relationships, hustle, and a thousand moving parts—but behind every order is a team buried in emails, messages, voicemails, and spreadsheets, manually trying to keep everything on track,” said Joseph (“JJ”) Jacob, Co-founder and CEO, Burnt. “I’ve experienced this first-hand, from working the shrimp factory floor to managing global procurement, and when I couldn’t find a solution, I began building one. With Burnt, we are creating supply chain superintelligence to eliminate the repetitive, invisible work and give time back to the people keeping the food industry moving.” 

The food supply chain is held back by legacy systems designed to securely store data in silos, not intelligently adapt to the dynamic, complex interconnectivity—and manual inputs—of the food industry. Beginning with an operational agent, Burnt captures orders from any source, such as emails, voicemails, and spreadsheets, and automatically inputs the data into existing ERP systems faster and more accurately. A sales order takes about 10 minutes to process, with hundreds coming in every minute—meaning an entire day is spent processing orders. With Burnt, the time per order takes seconds, essentially giving back a full workday to focus on customers. Burnt plans to expand with additional agents for teams across procurement, distribution, accounting, finance, and compliance.

Burnt is processing over $10 million worth of orders monthly for initial customers including top food distributors across meat, seafood and specialty foods, such as La Tua Pasta. Nicholas Hanson, Managing Director, La Tua Pasta, said, “After using other softwares that start-ups built, I saw why Burnt is different—they actually get the weird, wacky nuances of our world. They were relentless in making my team happy, and that’s why I backed them in their seed round. Now I can’t even imagine what life was like before Burnt.”

As graduates of Y Combinator’s S25 batch, Burnt’s founders are generational supply chain entrepreneurs with extensive expertise in every stage of the food supply chain – from farm to table. JJ (Joseph Jacob), Co-Founder and CEO, is a fourth-generation food supply chain entrepreneur, starting his career in a shrimp factory, before leading global procurement for one of the largest shrimp importers in America, to working at a Benchmark backed B2B marketplace for restaurants and suppliers called Rekki, building at the intersection of legacy food supply chain and venture-backed technology companies. Rhea Karimpanal, Co-Founder and CPO, is a third-generation food supply chain entrepreneur with roots in India’s spice trade, and experience building products and services for legacy industries like hospitality and travel with venture-backed companies like Fora Travel. Chandru Shanmugasundaram, Co-Founder and CTO, is a third-generation industry entrepreneur who started his technology career by building an in-house ERP for his father’s printing press company before holding key engineering roles with India’s top unicorn tech companies.

“JJ brings unmatched expertise to the food industry. He has lived every layer of it—from the factory floor to managing hundreds of millions in procurement—and that kind of knowledge can’t be picked up quickly by others. It comes only from years of firsthand exposure to the way this industry truly operates,” said Bryant Barr, Founding Partner, Penny Jar Capital. “That depth, combined with his relentless drive and refusal to accept the status quo, is why we bet on JJ and his team—and why we believe they’ll win.”

“What impresses me most about the Burnt team is they are not just outsiders looking to disrupt a historic industry with radical technology. Instead, they’ve lived this life and know all the nuances in workflows and where the real opportunity is to help,” said Dan Scheinman, angel investor. “That insider experience is exactly the kind of founder-market fit we look for.”

“Many founders are attacking obvious industries with agentic capabilities, but there are others that don’t get the same limelight where the opportunity set is equally massive. Food distribution is a $300 billion industry running on legacy systems that were installed some 25 years ago. It effectively skipped the SaaS generation. Any modern piece of software that breaks through will be in large part to a team’s customer sensibilities,” said Solly Garber, Formation. “JJ spent his entire life in this industry and it shows in the way the Burnt team architected and brought the product to market. We are seeing really encouraging early signs and think Burnt can one day be the central nervous system of the food distribution.”

“While the food supply chain relies on technology, there are still so many headaches and low efficiency workflows that result in massive opportunity costs,” said Elizabeth Weil, Founder & GP at Scribble Ventures. “Given their deep industry knowledge, the Burnt founders are the right team to build an AI solution that gives time back to the people who keep the food industry moving.”

About Burnt
Burnt is building superintelligence to strengthen the global supply chain. The company’s agentic platform will automate workflows stuck in legacy ERP systems – starting with the food supply chain. Founding members Joseph Jacob, Rhea Karimpanal and Chandru Shanmugasundaram, are generational supply chain entrepreneurs with extensive expertise from sales, to procurement and operations. For a demo and more information, please visit https://www.getburnt.ai/.

Press Contact
Teresa Brewer
[email protected]
408-368-6415

SOURCE Burnt

NEW YORK, Sept. 25, 2025 — Backcast Partners (“Backcast”), a leading provider of debt and equity capital for middle-market companies, is pleased to announce its most recent investment supporting the continued growth of Daniel Measurement and Control (“Daniel” or the “Company”), an existing Backcast portfolio company. Backcast’s investment was made alongside Daniel’s private equity sponsor, Turnspire Capital Partners (“Turnspire”), and provides Daniel with capital to support the ongoing growth in demand for its industry-leading metering products. Backcast’s partnership with Daniel began in 2021 when Backcast supported the acquisition of Daniel by Turnspire.

Headquartered in Houston with a state-of-the-art, strategically located manufacturing facility in Chihuahua, Mexico, Daniel is a global leader in providing flow and energy measurement technologies and services to the natural gas and refined hydrocarbon industries.

Backcast Managing Partner Mark Gudis said “We are excited to once again partner with Daniel and Turnspire in support of the growing demand for Daniel’s measurement solutions. Daniel is now well funded to capture and capitalize on this demand growth.”

CEO Tony Morris, said “Backcast has been a true partner to Daniel since their initial investment, and this transaction is yet another example of Backcast’s solutions-oriented and value-additive approach.”

Backcast was represented in the transaction by Greenberg Traurig.  

About Backcast Partners

Backcast Partners, formed in 2016, manages value-additive, credit-focused private investment funds providing capital to both private-equity backed and privately held management-owned companies. With approximately $1.4 billion in assets under management, the Backcast team has been supporting traditional middle-market companies ($7.5 million to $50 million of EBITDA) for decades. Backcast’s managed funds have a very flexible capital mandate and seek to invest from $20 million to up to $150 million per transaction. Backcast Partners operates out of offices in New York City and Millburn, NJ.

Information for companies seeking capital, please contact:

Mark Gudis, Managing Partner
[email protected]
(973) 512-7487
www.backcastpartners.com

Investor information, please contact:

David Petrucco, Managing Partner
[email protected]
(973) 512-7482
www.backcastpartners.com 

SOURCE Backcast Partners

Founded in 2023, the firm has already made twelve investments globally; portfolio includes one unicorn, a successful exit, and several up-rounds

SAN FRANCISCO, Sept. 25, 2025 — Touring Capital, the venture firm founded by industry veterans Nagraj Kashyap, Priya Saiprasad, and Samir Kumar, today announced the close of its Fund 1 with an oversubscribed $330 million in aggregate commitments. With an emphasis on AI-powered software startups at the early-growth stage, Touring Capital is helping a new generation of founders scale transformational businesses around the world.

Since launching in September 2023, the firm has made twelve investments, and has already demonstrated strong early results with five up-rounds and one exit. After leading SafeBase’s $33 million Series B, Touring Capital saw the company acquired by Drata within just 10 months. Its portfolio companies Netradyne, Daloopa, Numa, Cusp and Exaforce have announced up-rounds.

In addition, 50% of Touring Capital’s portfolio comes from former founders the team has previously backed, highlighting the strength of these repeat partnerships. Six of its twelve portfolio companies are led by entrepreneurs who chose to work with Touring Capital again.

Touring Capital’s momentum has extended beyond its portfolio, as the firm continues to scale its platform and presence, including opening its headquarters in South Park, San Francisco. The firm has also bolstered its team with the addition of Max Zhang as an associate, and rounded out its set of advisors with the addition of Sydney Meheula from Anthropic to join its existing advisory bench of Rajarshi Gupta, Ray Cao, and Abhi Kumar, all of whom have worked closely with the Touring team across prior funds.

“We launched Touring Capital with the belief that AI would redefine software and reshape productivity across industries. We’re seeing that conviction validated every day,” said Nagraj Kashyap, co-founder and general partner. “With this new fund, we’ll continue to support founders scaling the next generation of software companies.”

Touring Capital draws on decades of experience from its founding partners, who previously founded and held senior leadership roles at SoftBank Vision Fund II, M12 (Microsoft’s Venture Fund), and Qualcomm Ventures. Their combined track record includes 30 successful exits and investments in 17 unicorns, including Zoom, Kahoot!, Applied Intuition,  Outreach, Livongo, and Go1.

Touring Capital is backed by leading global institutional LPs, family offices, and more than 30 former founders who have worked with the team before—underscoring the firm’s reputation as a trusted, founder-first partner.

Touring Capital continues to seek early-growth opportunities in both established and emerging software ecosystems, as well as partnering with founders from its extensive network over time. 

To learn more about Touring Capital and its portfolio, visit touringcapital.com.

About Touring Capital:
Founded in 2023, Touring Capital is a venture capital firm focused on investing in the next generation of early growth-stage, AI-driven SaaS companies around the world. Its founders, Nagraj Kashyap, Priya Saiprasad, and Samir Kumar, have more than a decade of experience working together at leading investment firms and a proven track record of venture capital investing across the global technology startup ecosystem. The Touring Capital team is committed to investing in companies that are leveraging AI to fuel major productivity gains for workers across all lines of business and sectors. Visit https://touringcapital.com to learn more.

SOURCE Touring Capital

New Networking Initiative Set to Reignite Funding by Bridging the Gap Between Founders and the Right Investors

NEW YORK, Sept. 25, 2025 — Pendulum, the premier platform for invite-only events, today announced the launch of the Pendulum Founders Series, a networking initiative designed to connect founders with the investors shaping the future of business and technology.

The Founders Series will bridge the gap between startups and a carefully curated network of VCs, family offices, and angel investors. The event series will focus on technology and AI, while also spotlighting other high-growth sectors such as cybersecurity, robotics, Web3, and next-generation lifestyle innovations.

Founders will have the chance to meet potential co-founders, investors, and mentors through focused networking sessions, panels, and roundtables, designed to move past surface-level introductions and spark relationships that can truly drive business forward. The program will be unique for each event, combining networking opportunities with insights from top-tier venture capitalists and founders with proven track records.

New York and Los Angeles will serve as the flagship hubs for the Pendulum Founders Series. This strategic placement leverages the cities’ density of investors, unicorn founders, and sector-defining startups.

The program will debut with an invite-only gathering on Tuesday, October 14 in Los Angeles during LA Tech Week, followed by monthly founder panels in Los Angeles and New York City.

Pendulum will also host a Grand Prix event in Austin on Thursday, October 16.

“At its heart, the Founders Series is where you meet the person who could become your next co-founder, investor, or most trusted collaborator,” says Magnolia Sevenler, Founder of Pendulum. “We’ve created a curated space that cuts through the noise of traditional networking, where conversations are meaningful and connections have depth. Over time, we see this community expanding far beyond New York and Los Angeles, reaching our hubs in London, Singapore, Hong Kong, and other major cities around the world.”

Pendulum will anchor the series with a weekly newsletter featuring founder-crafted insights, delivering original content built by founders, for founders.

The Founders Series builds on Pendulum’s strong track record of hosting luxury experiences at cultural tentpoles such as Art Basel, Formula 1, New York Fashion Week and London Fashion Week, including collaborations with brands like Burberry. Through its production arm, Pendulum Live, the company has produced music festivals hosting over 8,000 people, with headliners such as Tiësto and The Chainsmokers. As the demand for curated professional gatherings grows, Pendulum offers a differentiated experience that combines prestige, exclusivity, and intent.

While networking clubs and business socials are surging in popularity, few deliver premium experiences or foster genuinely valuable connections. Even fewer generate significant buzz. Pendulum’s proven expertise in creating elevated events positions it uniquely to unite these dynamic communities.

Global startup funding reached $91 billion in Q2 2025, according to Crunchbase data, an 11% increase year over year. While still far below the previous peak levels of 2021, H1 2025 marks the strongest half-year for venture investment globally since the first six months of 2022, signaling tentative recovery in the private markets.

To learn more about becoming a member, please visit: https://pendulumfounderseries.com/.

About Pendulum
Pendulum is a members-only platform renowned for its high-caliber events at the intersection of business, culture, and innovation. Since 2022, it has curated unforgettable experiences for elite audiences worldwide, from Art Basel to Formula 1. To learn more, please visit: https://pendulummembers.com/.

Contact:
Julia Lazniuk
9739460276
[email protected]

SOURCE Pendulum

Investment led by Healthier Capital with Blue Venture Fund allows Daymark to continue supporting patients with cancer

PHILADELPHIA, Sept. 25, 2025 — Daymark Health, the company redefining the cancer care experience for patients, providers, and health plans, today announced a $20 million Series A funding round led by Healthier Capital with Blue Venture Fund, with participation from existing investors including Yosemite, Maverick Ventures, and Oncology Ventures.

Daymark delivers care to patients that addresses their clinical, social, and mental health needs both virtually and in the home, in collaboration with oncologists and primary care providers. The company’s comprehensive, tech-enabled cancer care platform and team of community-based clinicians provides patients with care navigation, 24/7 support, mental health assistance, symptom management, and social support. Daymark partners directly with health plans to align incentives to improve patient outcomes and manage the total cost of care.

“We are seeing a tipping point in oncology, where payers feel the ongoing pressures of managing specialty risk and providers are seeking solutions that put patients first,” said Dr. Justin Bekelman, oncologist and CEO and Co-Founder of Daymark Health. “We built Daymark Health to provide compassionate, intelligent, and frictionless cancer care at scale and are honored to partner with our new investors to advance cancer care across the U.S.”

Daymark Health’s $20 million financial investment from Healthier Capital and Blue Venture Fund will allow the company to continue scaling its cancer care platform, forging new partnerships with health plans and providers across the country and bringing its innovative technology platform to more patients.

Healthier Capital partners with technology-powered innovators to deliver healthier outcomes for all, and was founded by Amir Dan Rubin, former CEO of One Medical, the tech-enabled primary care organization which is now part of Amazon. Blue Venture Fund is a unique collaboration among Blue Cross and Blue Shield (BCBS) companies, the Blue Cross Blue Shield Association, and Sandbox, to which 36 BCBS companies and special purpose licensees have committed over $1.2 billion across five funds. The investment from these organizations underscores the industry-wide recognition that oncology is entering a period of rapid change, with payers and providers aligned on the need for more integrated, sustainable models of care. The company will add Healthier Capital’s Dr. Aman Mahajan and Blue Venture Fund’s Kelsey Maguire to its board.

“Daymark is breaking down the silos in healthcare delivery to better enable personalized care for patients with cancer, while improving outcomes and reducing avoidable costs,” said Aman Mahajan, MD, PhD, Partner at Healthier Capital. “Daymark is delivering a transformational model of personalized, high-quality, value-based cancer care.”

“Daymark and Blue Venture Fund are passionate about a shared purpose: to give all patients the best possible care experience, driving better health outcomes and ensuring they feel seen, heard, and valued,” said Kelsey Maguire, Managing Director at the Blue Venture Fund. “We’re thrilled to partner with Daymark as they redefine the cancer care experience and evolve what’s possible in value-based oncology.”

To learn more about Daymark Health, please visit www.daymarkhealth.com.

About Daymark Health
Daymark Health is a cancer care company that partners with health plans to provide in-home and virtual supportive and wraparound care to patients with cancer in collaboration with their own oncologists. Daymark’s supportive, personalized cancer care program empowers patients with care navigation, 24/7 support, mental health assistance, symptom management, and social support – all delivered virtually and in the home. For more information, visit www.daymarkhealth.com.

SOURCE Daymark Health

• Thyme Care achieves profitability, manages more than $5B in oncology spend, and extends access to 8M people nationwide in a landmark year of growth through new Medicare, commercial, and employer contracts
• With national scale and measurable outcomes, Thyme Care is positioned to take on more breaking points across the cancer journey and build an integrated oncology infrastructure grounded in value, accountability, and a better patient experience
• As cancer rates climb, Thyme Care dismantles barriers to care with an AI orchestration layer that leverages its connectivity across the cancer ecosystem to reduce cognitive overload on care teams, accelerate stakeholder integration, and deliver timely, personalized support to patients

NASHVILLE, Tenn., Sept. 25, 2025 — Thyme Care, the leading value-based cancer care enabler, today announced a $97M Series D fundraise from current investors CVS Health^® Ventures, Foresite Capital, a16z Bio + Health, Concord Health Partners, Town Hall Ventures, AlleyCorp, and Frist Cressey Ventures. New strategic investors include Morgan Health, a division of JPMorganChase focused on employer-sponsored healthcare, as well as Humana, Texas Oncology, and Memorial Hermann Health System, bringing Thyme Care’s total capital raised to $275M.

“This raise is overwhelmingly backed by strategic investors across the oncology care delivery landscape, including payers, providers, employers, and health systems who deeply understand the complex needs of oncology populations and who see firsthand the impact of Thyme Care’s model,” said Thyme Care President and Chief Operating Officer Brad Diephuis, MD. “This is evidence that oncology can lead the way in building scalable models of shared accountability and impact that healthcare has long needed.”

“The system was not designed for people with cancer, and too often patients fall through the cracks,” added Thyme Care Chief Executive Officer and Co-Founder Robin Shah. “My co-founder, Dr. Bobby Green, and I have seen this from the inside out for decades. We’ve witnessed it at the bedside in community practices and in building national infrastructures at Flatiron Health and OneOncology, and we founded Thyme Care to change it. Our next chapter is about scaling what works while exploring new ways to tackle the barriers that still make cancer care harder than it needs to be.”

Since its founding in 2020, Thyme Care has grown from concept to market leader by creating an integrated oncology infrastructure that reduces friction across the system. Thyme Care aligns incentives through partnerships with payers so that the best care for patients is also the most sustainable for the system. Working closely with more than 1,000 oncologists nationwide, Thyme Care reduces administrative burden, supports higher-value drug choices, strengthens clinical collaboration, and integrates services such as palliative care and survivorship uniquely into its model. For people with cancer, this fills the gaps and challenges they face day in and day out and translates to earlier interventions, fewer delays, and continuous support throughout the cancer journey. Together, these elements, powered by a purpose-built technology stack and high-performing care teams, enable earlier action, deeper engagement, and position Thyme Care as the backbone enabling oncology care to be more connected and scalable.

Thyme Care’s impact demonstrates systemic transformation across cost, experience, and provider efficiency, including:

• Creating a more connected and compassionate cancer journey: ~90% of members report feeling more supported with Thyme Care’s team of doctors, nurses, oncology social workers, and care partners. This connection ensures no one feels alone in their cancer journey. Because of that trust, 72% of members proactively share updates through electronic patient-reported outcome surveys (ePROs), nearly double the industry average, enabling faster interventions and more connected, compassionate care.
• Avoiding costly complications: Many hospital visits for people with cancer stem from symptoms like pain or nausea that can be safely managed at home with timely support. By intervening earlier, Thyme Care helps patients save time, energy, and money while allowing providers to focus on the highest-value care. Members who completed ePRO surveys were 40% less likely to visit the ER and had 19% fewer hospital admissions.
• Reducing provider burden: Oncology practices face rising volumes and administrative demands that pull providers away from patients. Thyme Care lightens the load by taking on time-consuming administrative and care coordination tasks, freeing capacity to focus on patient care. One Thyme Care Oncology Partner practice saved nearly 2,000 hours of staff time in a year, illustrating how Thyme Care enables providers to focus on what matters most: delivering high-quality, hands-on care.

With proven results at scale, Thyme Care is poised to target more breaking points in the oncology journey, with artificial intelligence—already deeply integrated into Thyme Care’s model—becoming a critical accelerant. By automating documentation, surfacing real-time insights and next-step guidance, and synthesizing complex patient data, AI can reduce the cognitive load on care teams and present the right insights at the right time. The result is more time to focus on people rather than paperwork, and a system that feels more connected and supportive for patients. In doing so, AI evolves from a useful tool into an invisible operating layer that makes high-quality, scalable cancer care possible. 

“Employers increasingly identify cancer as a top driver of their health care spend. At the same time, they care deeply about offering their employees access to high-quality, personalized cancer care – given the heavy burden that a diagnosis places on patients and their families,” said Dan Mendelson, CEO of Morgan Health. “Thyme Care can balance these needs and is already making early progress with Fortune 500 companies. They’ve demonstrated better coordination of patient care, improved outcomes and reduced costs. This approach aligns directly with our mission to scale specialist-led, value-based care for complex conditions in employer-sponsored insurance.”

“We continue to invest in Thyme Care because of the meaningful impact their model has on improving the lives of people with cancer,” said Vijay Patel, managing partner, CVS Health Ventures. “Through their technology, partnerships, and national scale, we’ve seen how Thyme Care can help deliver more coordinated interventions and a care experience that feels more connected, human, and affordable.”

About Thyme Care
Thyme Care is the leading value-based care enabler, collaborating with payers and providers to transform the experience and outcomes for individuals living with cancer. The company partners with health plans, employers and risk-bearing providers to assume accountability for enhanced care quality, improved health outcomes, and reduced total cost of care. Thyme Care’s approach combines a technology-enabled Care Team and seamless integration with providers, creating a hybrid collaborative care model that guides and supports the entire patient journey. Thyme Care empowers oncologists nationwide through purpose-built tech, advanced data analytics, and virtual patient engagement, driving better care and outcomes in value-based arrangements. To learn more about how Thyme Care is enabling the shift to value-based care in oncology, visit https://www.thymecare.com/

Contact
Kimberly Dreisinger
Thyme Care Communications
[email protected] 

SOURCE Thyme Care

Funds will support acceleration of product development to deliver actionable insights for global procurement managers

CHENNAI, India & RALEIGH, N.C., Sept. 25, 2025 — Beroe, the global leader in procurement decision intelligence, today announced a primary fundraise of $34m from a consortium of investors, through a minority stake dilution. The funding round was led by investors including Relativity Resilience Fund (Trust Group’s Private Equity platform), Mukul Agrawal, Ashish Kacholia, Lashit Sanghvi and Alchemy Long Term Ventures Fund.

The capital infusion will be strategically deployed to enhance and expand the insights layer of Beroe’s procurement intelligence stack, both through product development and inorganic growth via acquisitions, strengthening its ability to empower global procurement managers.

Beroe already delivers a strong intelligence layer and measurable outcomes to more than 1,000 global enterprise customers, including more than 300 of the Fortune 500. The company recently announced the acquisitions of Forestreet, the premier provider of supplier and innovation scouting solutions, in September 2025 and nnamu, the world’s first game theory enabled autonomous negotiation solution, in March 2025.

“We are thrilled to welcome such a distinguished group of investors who share our vision of transforming the procurement landscape. This funding will be instrumental in accelerating our product development and solidifying Beroe’s position as the decision workbench for procurement professionals worldwide,” said Vel Dhinagaravel, Founder & CEO at Beroe.

“Beroe has built a differentiated and scalable procurement intelligence ecosystem that is redefining how global enterprises approach sourcing. The successful raise of $34m, backed by marquee investors, is a strong validation of its vision and execution. We are proud to have partnered with Beroe on this milestone transaction and look forward to its continued global expansion,” Ramprasad Mathrubutham, Co-head, Investment Banking, InCred Capital.

“ProcureTech SaaS is one of most exciting spaces in enterprise technology, with AI-driven innovations helping global procurement teams drive value for their organizations. Beroe has established itself at the center of this momentum and we are looking forward to partnering with Vel and the Beroe team on their journey at the forefront of these developments,” said Vishesh Dalal, Partner, Relativity Resilience Fund.

“In today’s volatile global economy procurement is a mission-critical function. Beroe’s intelligence-driven platform helps global enterprises anticipate change and respond strategically. Its solutions are the choice of procurement leaders around the world and we are excited to continue to support its growth,” said Ashish Kacholia.

“Beroe has a history of challenging legacy approaches to market intelligence through cutting-edge technology and its recent acquisitions and product innovation show a clear vision for the future of procurement. We are excited to help accelerate this momentum in building the next generation of AI-led tools,” said Mukul Agrawal.

“The future of procurement isn’t about standalone tools, but about connected ecosystems. Beroe’s interoperability across multiple platforms has put them at the forefront of this transformation. We have recognized significant potential in its ability to lead the industry forward and are thrilled to be playing a part in building the future of procurement,” said Lashit Sanghvi.

InCred Capital acted as the exclusive financial advisor to Beroe on this fund raise.

About Beroe

Beroe has been on procurement’s leading edge since the company’s founding in 2006, bringing a world of insights forward. The unique combination of Beroe’s expertise, AI tools, and vast amounts of reliable data enable organizations to make smarter, faster, better procurement decisions. Not tomorrow, not today, but now. Selected by ProcureTech as one of the “most pioneering Analytics, Data and Intelligence solutions in 2024”, Beroe helps thousands of organizations sift through the data noise, mitigate risk, face fewer surprises, and ultimately gain a competitive edge.

www.beroeinc.com

Logo – https://mma.prnewswire.com/media/2542129/5528612/Beroe_Inc_Logo.jpg

SOURCE Beroe Inc.